Product logins

Find logins to all Clarivate products below.


Craniomaxillofacial Devices | Europe (Supplemental) | 2017 | Market Analysis

The European CMF device market will grow moderately through 2023 as rising procedure volumes—due to favorable demographics—and the increasing use of premium-priced products offset market limiters such as continuing economic difficulties, cuts to reimbursement, and pricing pressures.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the CMF device market in Europe, including country-level data for 5 major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Craniomaxillofacial Devices – Market Insights – United States
Growth in the US CMF device market will be primarily driven by favorable demographics, continuous improvements in physician training, and ongoing development of additive manufacturing. Additionally…